Ligand validation:3NYO

BU3: (R,R)-2,3-BUTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3NYO_BU3_B_583	51%	6%	0.215	0.972	5.04	0.28	4	-	0	0	100%	1
3NYO_BU3_A_583	28%	6%	0.289	0.944	4.96	0.32	4	-	0	0	100%	1
3NYN_BU3_B_583	56%	5%	0.197	0.969	5.05	0.51	4	-	1	0	100%	1
4AAN_BU3_A_1347	98%	74%	0.057	0.983	0.37	0.64	-	-	0	0	100%	1
1Z2U_BU3_A_201	97%	79%	0.067	0.984	0.36	0.51	-	-	0	0	100%	1
5AGV_BU3_B_513	96%	75%	0.068	0.977	0.54	0.44	-	-	0	0	100%	1
6R6U_BU3_B_502	92%	89%	0.071	0.962	0.11	0.52	-	-	0	0	100%	1
5LHM_BU3_A_1004	83%	95%	0.075	0.934	0.1	0.31	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.